Antiphospholipid syndrome in pregnancy: A controlled treatment trial

Completed

• Conditions: Pregnancy; antiphospholipid antibody syndrome; Pregnancy and Childbirth; Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

• Registration Number: ISRCTN55179279
• Lead Sponsor: HS R&D Regional Programme Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01-23
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 98

Inclusion Criteria

Pregnant women with antiphospholipid antibody syndrome

Exclusion Criteria

Does not match inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ive birth rate in both arms of the trial (defined as the live birth rate after 24 weeks gestation).

Secondary Outcome Measures

Name	Time	Method
The secondary outcome measures will concern maternal morbidity, e.g. osteoporosis, and fetal parameters, such as premature delivery and the incidence for small for dates.